| Umair Ahmed, | |
|
3500 Franciscan Way, Michigan City, IN 46360-0021 | |
| (219) 852-1524 | |
| (219) 933-2288 |
| Full Name | Umair Ahmed |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 8 Years |
| Location | 3500 Franciscan Way, Michigan City, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134579402 | NPI | - | NPPES |
| 300039834 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 125.069454 (Illinois) | Secondary |
| 207R00000X | Internal Medicine | 01084103A (Indiana) | Secondary |
| 208M00000X | Hospitalist | 01084103A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dunes Hospice Llc | Valparaiso, IN | Hospice |
| Harbor Light Hospice | Crown point, IN | Hospice |
| Harbor Light Hospice | Glen ellyn, IL | Hospice |
| Franciscan St Anthony Health - Michigan City | Michigan city, IN | Hospital |
| Saint Anthony | Crown point, IN | Nursing home |
| Golden Living Center-fountainview Terrace | La porte, IN | Nursing home |
| Beecher Manor Nrsg & Rehab Ctr | Beecher, IL | Nursing home |
| St James Wellness Rehab Villas | Crete, IL | Nursing home |
| Aperion Care Arbors Michigan City | Michigan city, IN | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Home Physicians Llc | 4981988771 | 37 |
| Community Home Physicians Llc | 4981988771 | 37 |
| Franciscan Physician Network | 3072790682 | 989 |
News Archive
Conclusive data show that hydroxyurea therapy offers safe and effective disease management of sickle cell anemia (SCA) and reduces the risk of stroke, prompting early termination by the National Heart Lung and Blood Institute of a key clinical trial studying the drug's efficacy.
Low birth weight and slow growth progressing to greater body mass in pre-adolescence significantly increased the risk of poor physical functioning at the age of 60 years, a new Finnish study published in the American Journal of Epidemiology found.
The diabetes drug metformin continues to expand beyond its treatment for type 2 diabetes. In addition to its potential use in treating age-related health problems, metformin can treat portal hypertension—high blood pressure in the liver resulting from cirrhosis, according to a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology.
A new peer-reviewed commentary published in the January issue of the American Journal of Public Health argues for new metrics to evaluate the public health response to HIV in the United States.
Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies.
› Verified 3 days ago
| Entity Name | Knd Development 59 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992034599 PECOS PAC ID: 3678602802 Enrollment ID: O20101021000962 |
News Archive
Conclusive data show that hydroxyurea therapy offers safe and effective disease management of sickle cell anemia (SCA) and reduces the risk of stroke, prompting early termination by the National Heart Lung and Blood Institute of a key clinical trial studying the drug's efficacy.
Low birth weight and slow growth progressing to greater body mass in pre-adolescence significantly increased the risk of poor physical functioning at the age of 60 years, a new Finnish study published in the American Journal of Epidemiology found.
The diabetes drug metformin continues to expand beyond its treatment for type 2 diabetes. In addition to its potential use in treating age-related health problems, metformin can treat portal hypertension—high blood pressure in the liver resulting from cirrhosis, according to a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology.
A new peer-reviewed commentary published in the January issue of the American Journal of Public Health argues for new metrics to evaluate the public health response to HIV in the United States.
Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies.
› Verified 3 days ago
| Entity Name | Community First Healthcare Of Illinois Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881059897 PECOS PAC ID: 2860716685 Enrollment ID: O20160104001552 |
News Archive
Conclusive data show that hydroxyurea therapy offers safe and effective disease management of sickle cell anemia (SCA) and reduces the risk of stroke, prompting early termination by the National Heart Lung and Blood Institute of a key clinical trial studying the drug's efficacy.
Low birth weight and slow growth progressing to greater body mass in pre-adolescence significantly increased the risk of poor physical functioning at the age of 60 years, a new Finnish study published in the American Journal of Epidemiology found.
The diabetes drug metformin continues to expand beyond its treatment for type 2 diabetes. In addition to its potential use in treating age-related health problems, metformin can treat portal hypertension—high blood pressure in the liver resulting from cirrhosis, according to a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology.
A new peer-reviewed commentary published in the January issue of the American Journal of Public Health argues for new metrics to evaluate the public health response to HIV in the United States.
Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies.
› Verified 3 days ago
| Entity Name | Community Home Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568909505 PECOS PAC ID: 4981988771 Enrollment ID: O20170222001318 |
News Archive
Conclusive data show that hydroxyurea therapy offers safe and effective disease management of sickle cell anemia (SCA) and reduces the risk of stroke, prompting early termination by the National Heart Lung and Blood Institute of a key clinical trial studying the drug's efficacy.
Low birth weight and slow growth progressing to greater body mass in pre-adolescence significantly increased the risk of poor physical functioning at the age of 60 years, a new Finnish study published in the American Journal of Epidemiology found.
The diabetes drug metformin continues to expand beyond its treatment for type 2 diabetes. In addition to its potential use in treating age-related health problems, metformin can treat portal hypertension—high blood pressure in the liver resulting from cirrhosis, according to a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology.
A new peer-reviewed commentary published in the January issue of the American Journal of Public Health argues for new metrics to evaluate the public health response to HIV in the United States.
Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Umair Ahmed, Po Box 781076, Detroit, MI 48278-1076 Ph: (317) 528-4800 | Umair Ahmed, 3500 Franciscan Way, Michigan City, IN 46360-0021 Ph: (219) 852-1524 |
News Archive
Conclusive data show that hydroxyurea therapy offers safe and effective disease management of sickle cell anemia (SCA) and reduces the risk of stroke, prompting early termination by the National Heart Lung and Blood Institute of a key clinical trial studying the drug's efficacy.
Low birth weight and slow growth progressing to greater body mass in pre-adolescence significantly increased the risk of poor physical functioning at the age of 60 years, a new Finnish study published in the American Journal of Epidemiology found.
The diabetes drug metformin continues to expand beyond its treatment for type 2 diabetes. In addition to its potential use in treating age-related health problems, metformin can treat portal hypertension—high blood pressure in the liver resulting from cirrhosis, according to a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology.
A new peer-reviewed commentary published in the January issue of the American Journal of Public Health argues for new metrics to evaluate the public health response to HIV in the United States.
Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies.
› Verified 3 days ago
Dr. Zain Sheikh, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3500 Franciscan Way, Michigan City, IN 46360 Phone: 219-879-8511 Fax: 219-933-2288 | |
Sanjay V Raikar, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3500 Franciscan Way, Michigan City, IN 46360 Phone: 219-879-8511 Fax: 219-877-2000 |